ABD - İngilizce - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - norpramin is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with norpramin or within 14 days of stopping treatment with norpramin is contraindicated because of an increased risk of serotonin syndrome. the use of norpramin within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration). starting norpramin in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration). norpramin is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

ABD - İngilizce - NLM (National Library of Medicine)

validus pharmaceuticals llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - norpramin is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with norpramin or within 14 days of stopping treatment with norpramin is contraindicated because of an increased risk of serotonin syndrome. the use of norpramin within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( s ee warnings and dosage and administration ). starting norpramin in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). norpramin is contraindicated in the acute recovery period following myocardial infarction.  it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

Kanada - İngilizce - Health Canada

ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 75mg - desipramine hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 50mg - desipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 25mg - desipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - desipramine hydrochloride - tablet - 50mg - desipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - desipramine hydrochloride - tablet - 10mg - desipramine hydrochloride 10mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - desipramine hydrochloride - tablet - 25mg - desipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

pharmascience inc - desipramine hydrochloride - tablet - 75mg - desipramine hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanada - İngilizce - Health Canada

ratiopharm inc division of teva canada limited - desipramine hydrochloride - tablet - 10mg - desipramine hydrochloride 10mg - tricyclics and other norepinephrine-reuptake inhibitors